Home/Filings/4/0001802768-25-000039
4//SEC Filing

Legorreta Pablo G. 4

Accession 0001802768-25-000039

CIK 0001802768other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 5:18 PM ET

Size

12.7 KB

Accession

0001802768-25-000039

Insider Transaction Report

Form 4
Period: 2025-05-08
Legorreta Pablo G.
DirectorCEO, Chairman of the Board
Transactions
  • Award

    Class A Ordinary Shares

    2025-05-08+288,352352,147 total
Holdings
  • Class A Ordinary Shares

    (indirect: By Son)
    10,000
  • Class A Ordinary Shares

    (indirect: By Trust)
    600,000
  • Class A Ordinary Shares

    (indirect: By LLC)
    460,139
  • Class A Ordinary Shares

    (indirect: By IRRA)
    123,310
  • Class A Ordinary Shares

    (indirect: By IRA)
    118,500
  • Class A Ordinary Shares

    (indirect: By Trust)
    1,040,410
  • Class A Ordinary Shares

    (indirect: By Trust)
    901,590
  • Class A Ordinary Shares

    (indirect: By Trust)
    41,306
  • Class A Ordinary Shares

    (indirect: By Spouse)
    6,930
  • Class A Ordinary Shares

    (indirect: By Tata MC 35 Ltd.)
    292,190
  • Class A Ordinary Shares

    (indirect: By Daughter)
    10,000
Footnotes (1)
  • [F1]Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

Issuer

Royalty Pharma plc

CIK 0001802768

Entity typeother

Related Parties

1
  • filerCIK 0001507678

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 5:18 PM ET
Size
12.7 KB